Skip to main content


Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology

  • Anette Bygum1Email author,
  • Emel Aygören-Pürsün2,
  • Teresa Caballero3,
  • Kathleen Beusterien4,
  • Shadi Gholizadeh4,
  • Patience Musingarimi5,
  • Suzanne Wait6 and
  • Henrik Boysen7
BMC Dermatology201212:4

DOI: 10.1186/1471-5945-12-4

Received: 9 November 2011

Accepted: 15 April 2012

Published: 26 April 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
9 Nov 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
6 Jan 2012 Reviewed Reviewer Report - Luigi Naldi
7 Mar 2012 Reviewed Reviewer Report - Asli Gelincik
11 Apr 2012 Author responded Author comments - Kathleen Beusterien
Resubmission - Version 3
11 Apr 2012 Submitted Manuscript version 3
15 Apr 2012 Editorially accepted
26 Apr 2012 Article published 10.1186/1471-5945-12-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

HAE Centre Denmark, Department of Dermatology and Allergy Centre, Odense University Hospital
Department of Pediatrics, Pediatric Hematology, Oncology, Hemostaseology and Cardiology, University Hospital, Johann Wolfgang Goethe University
Allergy Department, Hospital La Paz Health Research Center (IdiPaz), Biomedical Research Network on Rare Diseases U754 (CIBERER), University Hospital La Paz
Oxford Outcomes Inc
ViroPharma, Chatsworth House
SHW Health Ltd
HAEi–International Patient Organization for C1 Inhibitor Deficiencies